BIOCRYST PHARMACEUTICALS, INC. Public Float
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Public Float of $1.86 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $1.86B.
- 2024-06-30: Entity Public Float $1.26B.
- 2023-06-30: Entity Public Float $1.32B.
- 2022-12-31: Entity Public Float $1.95B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.86B 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.26B 10-K · filed 2025-02-25 |
| 2023-06-30 | $1.32B 10-K · filed 2024-02-27 |
| 2022-12-31 | $1.95B 10-K · filed 2023-02-27 |
| 2021-06-30 | $2.80B 10-K · filed 2022-02-28 |
| 2020-06-30 | $832.87M 10-K · filed 2021-03-01 |
| 2019-06-30 | $413.93M 10-K · filed 2020-03-13 |
| 2018-06-30 | $559.27M 10-K · filed 2019-03-14 |
| 2017-06-30 | $440.63M 10-K · filed 2018-03-12 |
| 2016-06-30 | $206.18M 10-K · filed 2017-02-27 |
| 2015-06-30 | $1.08B 10-K · filed 2016-02-26 |
| 2014-06-30 | $903.00M 10-K · filed 2015-03-02 |
| 2013-06-30 | $83.06M 10-K · filed 2014-03-10 |
| 2012-06-30 | $197.33M 10-K · filed 2013-03-11 |
| 2011-06-30 | $109.54M 10-K · filed 2012-03-06 |
| 2010-06-30 | $194.01M 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |